Nevertheless, given the association between the presence of CD8+ and expression of PD-1 and PDL-1 in the tumor, immunoscore is an attractive potential predictive marker of response to checkpoint inhibitors, and certainly one worth further investigating across tumor types (Galon et al., 2006). This evidence concerns the gene CD274 and neoplasm.